SAN FRANCISCO, Oct. 31, 2024 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2024 on Thursday, November 7, 2024, after the close of U.S.-based financial markets. Howard Robin, […]
Tag: Nektar Therapeutics
Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024
– New proteomic analyses show that rezpegaldesleukin increases the protein levels of immune-regulating pathways while reducing specific serum proteins known to be elevated in patients with atopic dermatitis – SAN FRANCISCO, Sept. 25, 2024 /PRNewswire/ […]
